Page last updated: 2024-08-24

ursolic acid and Alzheimer Disease

ursolic acid has been researched along with Alzheimer Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Gunji, H; Hanaki, M; Ido, K; Irie, K; Midorikawa, S; Murakami, K; Taniwaki, S; Yamaguchi, K; Yoshioka, T1
An, HM; Chen, L; Gu, C; Hu, B; Peng, X; Qu, YJ; Zhang, LM; Zhen, RR1
Ahmed, T; Amber, S; Hassan, D; Mirza, FJ; Zahid, S1
Ho, CT; Jeong, WS; Jun, M; Karwe, MV; Yoon, JH; Youn, K1
Chung, YK; Heo, HJ; Huh, TL; Kim, EK; Kim, HK; Kim, SK; Lim, Y; Shin, DH1
Cho, HY; Heo, HJ; Heo, TR; Hong, B; Kim, CJ; Kim, EK; Kim, HK; Kim, SK; Shin, DH1

Other Studies

6 other study(ies) available for ursolic acid and Alzheimer Disease

ArticleYear
Semisynthesis and Structure-Activity Studies of Uncarinic Acid C Isolated from Uncaria rhynchophylla as a Specific Inhibitor of the Nucleation Phase in Amyloid β42 Aggregation.
    Journal of natural products, 2016, 10-28, Volume: 79, Issue:10

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Survival; Drugs, Chinese Herbal; Humans; Japan; Molecular Structure; Neurons; Peptide Fragments; Rifamycins; Structure-Activity Relationship; Triterpenes; Uncaria

2016
Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer's disease through a network pharmacology approach.
    BMC complementary medicine and therapies, 2020, May-25, Volume: 20, Issue:1

    Topics: Allylbenzene Derivatives; Alzheimer Disease; Anisoles; Cornus; Drugs, Chinese Herbal; Humans; Protein Interaction Maps; Signal Transduction; Sitosterols; Triterpenes; Ursolic Acid

2020
Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an Aβ
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 83

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cinnamates; Cognition; Depsides; Disease Models, Animal; Doublecortin Protein; Gene Expression Regulation; Hippocampus; Male; Maze Learning; Mice, Inbred BALB C; Neurogenesis; Neurons; Neuroprotective Agents; Peptide Fragments; Rosmarinic Acid; Rosmarinus; Triterpenes; Ursolic Acid

2021
p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid(25-35)-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells.
    Journal of agricultural and food chemistry, 2014, May-28, Volume: 62, Issue:21

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cornus; Coumaric Acids; Humans; MAP Kinase Signaling System; Neuroprotective Agents; NF-kappa B; Phosphorylation; Plant Extracts; Propionates; Rats; Triterpenes; Ursolic Acid

2014
Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase.
    Molecules and cells, 2001, Apr-30, Volume: 11, Issue:2

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Chromatography; Humans; Lamiaceae; Molecular Structure; PC12 Cells; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats; Tacrine; Triterpenes; Ursolic Acid

2001
Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury.
    Molecules and cells, 2002, Feb-28, Volume: 13, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Death; Humans; Lamiaceae; Lipid Peroxidation; PC12 Cells; Rats; Reactive Oxygen Species; Triterpenes; Ursolic Acid; Vitamin E

2002